StocksHealthcareRMD

RMD

ResMed Inc.
NYSEResearch view
Healthcare · Surgical & Medical Instruments & Apparatus · Large-cap · SEC EDGAR FY 2026-06-30

Price history

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2026-06-30
SectorHealthcare
Market Cap$31.5B
Enterprise Value$30.4B
Income$1.5B
Sales$5.7B
Book/sh$45.65
Cash/sh$10.19
Dividend TTM$2.40
Payout23%
Employees
IPO
Quick Ratio2.42
Current Ratio3.10
Debt/Eq0.06
EPS (ttm)$10.43
EPS this Y9.7%
EPS past 3/5Y19.6%
Sales past 3/5Y10.2%
EPS Y/Y TTM9.7%
Sales Y/Y TTM9.9%
Shs Outstand144.25M
ROA17.0%
ROE23.1%
ROIC27.1%
Gross Margin61.1%
Oper. Margin33.4%
Profit Margin26.9%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.
Revenue & Earnings — fiscal year
$3.6B
2022
$4.2B
2023
$4.7B
2024
$5.1B
2025
$5.7B
2026

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2022FY2023FY2024FY2025FY2026

Deep dive

Computed from the SEC EDGAR multi-year statements

Operating leverage — margins

GrossOperatingNet
0%40%80%61%33%27%FY22FY23FY24FY25FY26

FY26 cash-flow waterfall

Capital-light: capex is $156.3M against $1.8B operating cash
$1.8BOperating CF$156.3M− Capex$1.6BFree CF
COMMUNITY · $RMD0 theses
POST YOUR TAKE →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.